SCHEMBL8934515

SCHEMBL8934515

Cc1cccc2c(O)c(Cc3ccccc3)c(=O)oc12

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NQO1 P15559 8/20 0.64
KDM4E B2RXH2 3/20 0.59
GAA P10253 3/20 0.59
MAPK1 P28482 2/20 0.59
JAK2 O60674 1/20 0.59
POLB P06746 1/20 0.59
MAPT P10636 1/20 0.59
PKM P14618 1/20 0.59
MPI P34949 1/20 0.59
HTT P42858 1/20 0.59
BLM P54132 1/20 0.59
MCL1 Q07820 1/20 0.59
SMN1; SMN2 Q16637 1/20 0.59
SHBG P04278 1/20 0.56
CNR2 P34972 2/20 0.53
GPR55 Q9Y2T6 2/20 0.53
VKORC1 Q9BQB6 5/20 0.51
ALDH1A1 P00352 2/20 0.50
LMNA P02545 2/20 0.50
MEN1 O00255 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8945371 0.80 NQO1 (0.52) NQO1KDM4EGAAPOLBMAPT
SCHEMBL7800243 0.80 NQO1 (0.51) NQO1KDM4EMAPK1MCL1ALDH1A1
SCHEMBL1648186 0.78 NQO1 (1.00) NQO1MAPK1VKORC1ALDH1A1LMNA
SCHEMBL8381781 0.77 MCL1 (0.54) NQO1KDM4EMAPTHTTMCL1
SCHEMBL11491095 0.75 ERAP1 (0.49) KDM4EGAAPOLBMAPTPKM
SCHEMBL2839705 0.74 KDM4E (1.00) NQO1KDM4EGAAMAPK1JAK2
SCHEMBL8934532 0.74 NQO1 (0.79) NQO1KDM4EGAAMAPK1VKORC1
SCHEMBL8945542 0.73 CNR2 (0.52) NQO1POLBMAPTCNR2GPR55
SCHEMBL9842105 0.72 MCL1 (0.56) NQO1KDM4EGAAMAPK1JAK2
SCHEMBL4389522 0.71 ALDH1A1 (0.67) KDM4EGAAPOLBMAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1996031206-A2 FLAVONES AND COUMARINS AS AGENTS FOR THE TREATMENT OF ATHEROSCLEROSIS WARNER-LAMBERT COMPANY (US) 1996-10-10 WO claimed
WO-1996031206-A2 FLAVONES AND COUMARINS AS AGENTS FOR THE TREATMENT OF ATHEROSCLEROSIS WARNER-LAMBERT COMPANY (US) 1996-10-10 WO disclosed